I don't get your question. I made a reference to, you don't cut of your nose despite your face. Why would you sell a golden goose when it's producing on a regular basis? IMO AMBS won't sell Lympro right now for a couple reasons. Gerald has mentioned Dx several times so he really wants that division. Secondly, I doubt BP is willing it pony up 1-2B or more right now that AMBS believes Lympro is worth. Looks like I may have to resign myself into just letting these shares sit for a while. Hopefully, during next few quarters revenues will increase at a greater rate than the runway.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links